Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-401017

Chief Executive Officer sold 2,210 shares at an average $39.17 ($86,565)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ceesay Abraham Chief Executive Officer 2026-09-23 Sale 10b5-1 −1,952 $39.05 $76,230 457,025 D
Ceesay Abraham Chief Executive Officer 2026-09-23 Sale 10b5-1 −215 $39.86 $8,570 456,810 D
Ceesay Abraham Chief Executive Officer 2026-09-23 Sale 10b5-1 −43 $41.05 $1,765 456,767 D
Open-market sales · 2,210 sh · avg $39.17 · $86,565
Loading xslF345X06/ownership.xml…